Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Rainbow Coral Corp. (RBCC) Poised For Rapid Growth As Personalized Medicine Market Continues To Expand 0 comments
    Jul 11, 2013 10:23 AM | about stocks: RBCC

    Rainbow Coral Corp. is focused on delivering profitable new medical technologies and innovations. Targeting the fast-growing, $232 billion personalized medicine market, Rainbow Coral is well positioned for the future as the sector could nearly double to $452 billion by 2015, according to PricewaterhouseCoopers.

    Today the company reports the rapid transition of molecular pathology tests from the laboratory to the clinic. GEN magazine recently said that clinical laboratories began billing for more than 100 molecular pathology tests using new CPT codes on the first of this year, replacing the previous stacked-code system. This development means the valuable testing will be available to more patients through their insurance providers, opening up personalized medicine to a much wider audience.

    "We're beginning to see patient care billers recognize that these tests work and provide value to the patient, the physician and the healthcare system," stated RBCC CEO Patrick Brown. "That's a big breakthrough: Insurance coverage decisions and physician test usage are big drivers of clinical utility."

    RBCC told investors it is developing a comprehensive media and marketing strategy designed to introduce new innovations and treatment options in the personalized medicine market. RBCC has formed a biotech subsidiary, Rainbow BioSciences, to market and develop new medical and research technology innovations to compete alongside companies such as Bristol Myers Squibb Co. (NYSE: BMY), Biogen Idec Inc. (NASDAQ: BIIB), Abbott Laboratories (NYSE: ABT) and Amgen Inc. (NASDAQ: AMGN).

    For more information on the company, please visit rainbowbiosciences.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: RBCC
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.